Expansion of mesenchymal stem cells on fibrinogen-rich protein surfaces derived from blood plasma

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 8, 2011, Pages 600-611

  Kisiday, John D ^a   Hale, Benjamin W ^a   Almodovar, Jorge L ^b   Lee, Christina M ^a   Kipper, Matt J ^b   Wayne Mcilwraith, C ^a   Frisbie, David D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Engineering Research Center and Hydraulics Laboratory   (United States)

Author keywords

Cartilage tissue engineering; Cell proliferation; Chondrogenesis; Fibrinogen; Growth substrate; Mesenchymal stem cell

Indexed keywords

BLOOD; CELL ENGINEERING; EXPANSION; FLOWCHARTING; STEM CELLS; SUBSTRATES; TISSUE; TISSUE CULTURE; TISSUE ENGINEERING;

BLOOD PLASMA; CARTILAGE TISSUE ENGINEERING; CELL YIELDS; CHONDROGENESIS; FIBRINOGEN; FIBROBLAST GROWTH FACTOR-2; GROWTH SUBSTRATES; LOWER DENSITY; MESENCHYMAL STEM CELL; TISSUE CULTURE PLASTICS;

CELL PROLIFERATION;

FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; FIBRINOGEN RICH PRECIPITATE; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PLASMA; PRECIPITATION; PRIORITY JOURNAL; TISSUE CULTURE; TISSUE CULTURE PLASTIC;

EID: 79960518142     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.352     Document Type: Article

References (62)

1. Ahmed TA, Dare EV, Hincke M. 2008; Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng B Rev 14(2): 199-215.
2. Bensaid W, Triffitt JT, Blanchat C, et al. 2003; A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24(14): 2497-2502.
3. Bianchi G, Banfi A, Mastrogiacomo M, et al. 2003; Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287(1): 98-105.
4. Boddohi S, Killingsworth CE, Kipper MJ. 2008; Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin. Biomacromolecules 9(7): 2021-2028.
5. Bruder SP, Jaiswal N, Haynesworth SE. 1997; Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64(2): 278-294.
6. Caplan AI. 2007; Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213(2): 341-347.
7. Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, et al. 2008; Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36(8): 1014-1021.
8. Colter DC, Class R, DiGirolamo CM, Prockop DJ. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97(7): 3213-3218.
9. Desroches MJ, Omanovic S. 2008; Adsorption of fibrinogen on a biomedical-grade stainless steel 316LVM surface: a PM-IRRAS study of the adsorption thermodynamics, kinetics and secondary structure changes. Phys Chem Chem Phys 10(18): 2502-2512.
10. DiGirolamo CM, Stokes D, Colter D, et al. 1999; Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107(2): 275-281.
11. D'Ippolito G, Diabira S, Howard GA, et al. 2004; Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117(14): 2971-2981.
12. Doucet C, Ernou I, Zhang Y, et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205(2): 228-236.
13. Evans CH, Palmer GD, Pacher A, et al. 2007; Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 13(8): 1987-1993.
14. Frisbie DD, Bowman SM, Colhoun HA, et al. 2008; Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects: results at 12 and 18 months. Osteoarthr Cartilage 16(6): 667-679.
15. Gailit J, Clarke C, Newman D, et al. 1997; Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3. Exp Cell Res 232(1): 118-126.
16. Greiling D, Clark RA. 1997; Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110(7): 861-870.
17. Hashimoto J, Kariya Y, Miyazaki K. 2006; Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells 24(11): 2346-2354.
18. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992; Characterization of cells with osteogenic potential from human marrow. Bone 13(1): 81-88.
19. Ho W, Tawil B, Dunn JC, Wu BM. 2006; The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12(6): 1587-1595.
20. Huang CY, Deitzer MA, Cheung HS. 2007; Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels. Biomech Model Mechanobiol 6(1-2): 5-11.
21. Huang CY, Reuben PM, D'Ippolito G, et al. 2004; Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 278(1): 428-436.
22. Ito T, Sawada R, Fujiwara Y, et al. 2007; FGF-2 suppresses cellular senescence of human mesenchymal stem cells by downregulation of TGF-β2. Biochem Biophys Res Commun 359(1): 108-114.
23. Javazon EH, Beggs KJ, Flake AW. 2004; Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32(5): 414-425.
24. Javazon EH, Colter DC, Schwarz EJ, Prockop DJ. 2001; Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 19(3): 219-225.
25. Johnstone B, Hering TM, Caplan AI, et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238(1): 265-272.
26. Kisiday JD, Kopesky PW, Evans CH, et al. 2008; Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 26(3): 322-331.
27. Lange C, Cakiroglu F, Spiess AN, et al. 2007; Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transniantation and regenerative medicine. J Cell Physiol 213(1): 18-26.
28. Larson BL, Ylostalo J, Prockop DJ. 2008; Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 26(1): 193-201.
29. Lee KB, Hui JH, Song IC, et al. 2007; Injectable mesenchymal stem cell therapy for large cartilage defects-a porcine model. Stem Cells 25(11): 2964-2971.
30. Mannello F, Tonti GA. 2007; Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25(7): 1603-1609.
31. Mareddy SR, Crawford R, Brooke G, Xiao Y. 2007; Clonal isolation and characterization of bone marrow stromal cells from osteoarthritis patients. Bone 40(6): S168-168.
32. Martin I, Muraglia A, Campanile G, et al. 1997; Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138(10): 4456-4462.
33. Matsubara T, Tsutsumi S, Pan H, et al. 2004; A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun 313(3): 503-508.
34. Mauck RL, Yuan X, Tuan RS. 2006; Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthr Cartilage 14(2): 179-189.
35. Mauney JR, Volloch V, Kaplan DL. 2005; Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 26(31): 6167-6175.
36. Murphy JM, Fink JD, Hunziker EB, Barry FP. 2003; Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48(12): 3464-3474.
37. Muschler GF, Nitto H, Boehm CA, Easley KA. 2001; Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19(1): 117-125.
38. Neuhuber B, Swanger SA, Howard L, et al. 2008; Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36(9): 1176-1185.
39. Phinney DG, Kopen G, Righter W, et al. 1999; Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75(3): 424-436.
40. Sah RL, Kim YJ, Doong JY, et al. 1989; Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 7(5): 619-636.
41. Sahni A, Odrljin T, Francis CW. 1998; Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273(13): 7554-7559.
42. Sahni A, Sporn LA, Francis CW. 1999; Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem 274(21): 14936-14941.
43. Salvade A, Della Mina P, Gaddi D, et al. 2009; Characterization of platelet lysate (PL)-cultured mesenchymal stromal cells (MSC) and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng C Methods 16(2): 201-214.
44. Schmal H, Niemeyer P, Roesslein M, et al. 2007; Comparison of cellular functionality of human mesenchymal stromal cells and PBMC. Cytotherapy 9(1): 69-79.
45. Schuleri KH, Amado LC, Boyle AJ, et al. 2008; Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294(5): H2002-2011.
46. Shahdadfar A, Fronsdal K, Haug T, et al. 2005; In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23(9): 1357-1366.
47. Siddappa R, Licht R, van Blitterswijk C, de Boer J. 2007; Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25(8): 1029-1041.
48. Silver FH, Wang MC, Pins GD. 1995a; Preparation and use of fibrin glue in surgery. Biomaterials 16(12): 891-903.
49. Silver FH, Wang MC, Pins GD. 1995b; Preparation of fibrin glue: a study of chemical and physical methods. J Appl Biomater 6(3): 175-183.
50. Solchaga LA, Penick K, Porter JD, et al. 2005; FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203(2): 398-409.
51. Sotiropoulou PA, Perez SA, Salagianni M, et al. 2006; Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24(2): 462-471.
52. Stolzing A, Jones E, McGonagle D, Scutt A. 2008; Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129(3): 163-173.
53. Stute N, Holtz K, Bubenheim M, et al. 2004; Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32(12): 1212-1225.
54. Tunc S, Maitz MF, Steiner G, et al. 2005; In situ conformational analysis of fibrinogen adsorbed on Si surfaces. Colloids Surf B Biointerfaces 42(3-4): 219-225.
55. Vidal MA, Kilroy GE, Johnson JR, et al. 2006; Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 35(7): 601-610.
56. Wakitani S, Goto T, Pineda SJ, et al. 1994; Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76(4): 579-592.
57. Wang J, Chen X, Clarke ML, Chen Z. 2006; Vibrational spectroscopic studies on fibrinogen adsorption at polystyrene/protein solution interfaces: hydrophobic side chain and secondary structure changes. J Phys Chem B 110(10): 5017-5024.
58. Wilke MM, Nydam DV, Nixon AJ, et al. 2007; Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25(7): 913-925.
59. Worster AA, Brower-Toland BD, Fortier LA, et al. 2001; Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-β1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19(4): 738-749.
60. Yoshida H, Hirozane K, Kamiya A. 1999; Comparative study of autologous fibrin glues prepared by cryo-centrifugation, cryo-filtration, and ethanol precipitation methods. Biol Pharm Bull 22(11): 1222-1225.
61. Zangi L, Rivkin R, Kassis I, et al. 2006; High-yield isolation, expansion, and differentiation of rat bone marrow-derived mesenchymal stem cells with fibrin microbeads. Tissue Eng 12(8): 2343-2354.
62. Zhou S, Greenberger JS, Epperly MW, et al. 2008; Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7(3): 335-343.